Use human EPSC-derived cells in vivo functional studies and for testing drug candidates

CTSCB aims to generate chimeric animals that have human cells or tissues derived from transplantation of functional human cells generated from genome edited human EPSCs that can escape animal host immune rejections, under proper ethical approvals.